Caption Management’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.34M | Hold |
264,910
| – | – | 0.03% | 129 |
|
|
2025
Q1 | $2.07M | Buy |
+264,910
| New | +$2.07M | 0.02% | 118 |
|
|
2024
Q4 | – | Sell |
-123,002
| Closed | -$1.61M | – | 550 |
|
|
2024
Q3 | $1.61M | Buy |
123,002
+118,502
| +2,633% | +$1.55M | 0.03% | 119 |
|
|
2024
Q2 | $63.3K | Sell |
4,500
-31,596
| -88% | -$444K | ﹤0.01% | 338 |
|
|
2024
Q1 | $610K | Sell |
36,096
-29,012
| -45% | -$490K | 0.01% | 194 |
|
|
2023
Q4 | $919K | Sell |
65,108
-15,992
| -20% | -$226K | 0.01% | 160 |
|
|
2023
Q3 | $835K | Buy |
81,100
+13,907
| +21% | +$143K | 0.01% | 162 |
|
|
2023
Q2 | $1.11M | Sell |
67,193
-48,311
| -42% | -$796K | 0.02% | 113 |
|
|
2023
Q1 | $1.06M | Buy |
+115,504
| New | +$1.06M | 0.02% | 120 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 464 |
|
|
2022
Q1 | – | Sell |
-190,000
| Closed | -$1.54M | – | 550 |
|
|
2021
Q4 | $1.54M | Buy |
190,000
+40,000
| +27% | +$323K | 0.02% | 203 |
|
|
2021
Q3 | $1.47M | Buy |
150,000
+105,808
| +239% | +$1.04M | 0.02% | 211 |
|
|
2021
Q2 | $298K | Hold |
44,192
| – | – | ﹤0.01% | 312 |
|
|
2021
Q1 | $400K | Buy |
+44,192
| New | +$400K | 0.01% | 248 |
|
|
2020
Q4 | – | Sell |
-84,600
| Closed | -$427K | – | 333 |
|
|
2020
Q3 | $427K | Buy |
+84,600
| New | +$427K | 0.01% | 209 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 324 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 333 |
|